Abstract
The various scaling methodologies and molecular features analysis were applied to new dataset to predict human pharmacokinetics studies. Whereas the predictive accuracies demonstrated across all of the various methodologies were lower for this higher clearance compound dataset, scaling from species continued to be an accurate methodology, and human volume of distribution was similarly well predicted regardless of scaling methodology. Also, extrapolation is the method for constructing new data points given a set of discrete data points. Methods estimate is reasonably reliable for short times, but for longer times, the estimate is liable to become less accurate. Species Scaling and Extrapolation are useful for acquiring toxicological data- epidemiological and experimental study. Animal studies help us to understand toxicity characteristics of a chemical before human exposure is allowed, whereas the epidemiological method generally does not. Species scaling and extrapolation from animals is necessary in many cases which helps in dealing with the socalled human risks more properly.
Keywords: Species scaling, extrapolation, pharmacokinetics, clearance, metabolism
Current Drug Metabolism
Title: Species Scaling and Extrapolation
Volume: 9 Issue: 3
Author(s): Virendra S. Gomase and Somnath Tagore
Affiliation:
Keywords: Species scaling, extrapolation, pharmacokinetics, clearance, metabolism
Abstract: The various scaling methodologies and molecular features analysis were applied to new dataset to predict human pharmacokinetics studies. Whereas the predictive accuracies demonstrated across all of the various methodologies were lower for this higher clearance compound dataset, scaling from species continued to be an accurate methodology, and human volume of distribution was similarly well predicted regardless of scaling methodology. Also, extrapolation is the method for constructing new data points given a set of discrete data points. Methods estimate is reasonably reliable for short times, but for longer times, the estimate is liable to become less accurate. Species Scaling and Extrapolation are useful for acquiring toxicological data- epidemiological and experimental study. Animal studies help us to understand toxicity characteristics of a chemical before human exposure is allowed, whereas the epidemiological method generally does not. Species scaling and extrapolation from animals is necessary in many cases which helps in dealing with the socalled human risks more properly.
Export Options
About this article
Cite this article as:
Gomase S. Virendra and Tagore Somnath, Species Scaling and Extrapolation, Current Drug Metabolism 2008; 9 (3) . https://dx.doi.org/10.2174/138920008783884786
DOI https://dx.doi.org/10.2174/138920008783884786 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets The Role and Modulation of the Oxidative Balance in Pregnancy
Current Pharmaceutical Design Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation
Current Pharmaceutical Biotechnology The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Current Pharmaceutical Design Functional Interactions Between B Lymphocytes and the Innate Immune System
Infectious Disorders - Drug Targets Role of Free Radicals in Sepsis: Antioxidant Therapy
Current Pharmaceutical Design The Early Involvement of the Innate Immunity in the Pathogenesis of Lateonset Alzheimers Disease: Neuropathological, Epidemiological and Genetic Evidence
Current Alzheimer Research HIV-1 Cell-to-Cell Transmission and Antiviral Strategies: An Overview
Current Drug Targets Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Current Pharmaceutical Design Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options
Current Cancer Therapy Reviews Limitations of Current Antiretroviral Agents and Opportunities for Development
Current Pharmaceutical Design Neutrophil Function in Severe Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Adenosine A1 Receptors in the Central Nervous System: Their Functions in Health and Disease, and Possible Elucidation by PET Imaging
Current Medicinal Chemistry Pharmacological Chaperones that Protect Tetrahydrobiopterin Dependent Aromatic Amino Acid Hydroxylases Through Different Mechanisms
Current Drug Targets The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
Current Drug Targets - Cardiovascular & Hematological Disorders Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Current Enzyme Inhibition Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery